chartexchange

Amphastar Pharmaceuticals Reports Q3 Revenue of $207.6 Million and GAAP EPS of $0. ...

GuruFocus | Nov 5, 2026 4:53 PM EST

Revenue of $207.6 Million and Adjusted EPS of $1.14 Both Beat Analyst Forecasts Related Stocks: AMPH ,

Read original article